Showing 1 - 10 of 312
Two discrete choice experiments conducted early in the Covid-19 vaccination campaign show that people dramatically … found that median willingness to pay (WTP) for initial vaccination is around $50, only 2 percent of the WTP implied by … private benefits of vaccination suggests that there may be a role for government beyond conventional efforts to correct …
Persistent link: https://www.econbiz.de/10013334337
We propose an approach to modeling and estimating discrete choice demand that allows for a large number of zero sale observations, rich unobserved heterogeneity, and endogenous prices. We do so by modeling small market sizes through Poisson arrivals. Each of these arriving consumers then solves...
Persistent link: https://www.econbiz.de/10012794558
Conventional hedonic techniques for estimating the value of local amenities rely on the assumption that households move freely among locations. We show that when moving is costly, the variation in housing prices and wages across locations may no longer reflect the value of differences in local...
Persistent link: https://www.econbiz.de/10012466562
Amenities that vary across cities are typically valued using either a hedonic model, in which amenities are capitalized into wages and housing prices, or a discrete model of household location choice. In this paper, we use the 2000 Public Use Microdata Sample (PUMS) to value climate amenities...
Persistent link: https://www.econbiz.de/10012453424
The decades-long effort to produce a workable HIV vaccine has hardly been a waste of public and private resources. To the contrary, the scientific know-how acquired along the way has served as the critical foundation for the development of vaccines against the novel, pandemic SARS-CoV-2 virus....
Persistent link: https://www.econbiz.de/10012496141
We argue that in pharmaceutical markets, variation in the arrival time of consumer heterogeneity creates differences between a producer's ability to extract consumer surplus with preventives and treatments, potentially distorting R&D decisions. If consumers vary only in disease risk, revenue...
Persistent link: https://www.econbiz.de/10012459799
Persistent link: https://www.econbiz.de/10001484280
Several programs have been proposed to improve incentives for research on vaccines for malaria, tuberculosis, and HIV, and to help increase accessibility of vaccines once they are developed. For these programs to spur research, potential vaccine developers must believe that the sponsor will not...
Persistent link: https://www.econbiz.de/10012471044
Malaria, tuberculosis, and the strains of HIV common in Africa kill approximately 5 million people each year. Yet research on vaccines for these diseases remains minimal largely because potential vaccine developers fear that they would not be able to sell enough vaccine at a sufficient price to...
Persistent link: https://www.econbiz.de/10012471045
Millions of people refuse COVID-19 vaccination. Using original data from two surveys in nine OECD countries, we analyze …
Persistent link: https://www.econbiz.de/10012938710